Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

flobufen

Known as: 4-(2,4-difluorbiphenylyl)-4-oxo-2-methylbutanoic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PurposeDodecyl-6-aminohexanoate (DDEAC) is a transdermal permeation enhancer with excellent activity, low toxicity, and no dermal… Expand
  • figure 1
  • table I
  • figure 3
  • table II
  • figure 2
2005
2005
Two vancomycin-based chiral stationary phases (CSPs) with different coverage of the chiral selector vancomycin (Chirobiotic V and… Expand
2004
2004
AbstractPurpose. The aim of this study was to obtain the resolution of flobufen enantiomers, an antiinflammatory active substance… Expand
  • table I
  • figure 2
  • figure 1
  • table II
  • figure 3
2001
2001
Flobufen (F) is the original nonsteroidal antiinflammatory drug (NSAID) containing two enantiomers. The aim of this investigation… Expand
1999
1999
Stereoselectivity of the pharmacokinetics of the nonsteroidal anti-inflammatory drug flobufen, 4-(2', 4'-difluorobiphenyl-4-yl)-2… Expand
1999
1999
The enantioselective behaviour of some underivatized 2-arylpropionic acids (profens) and flobufen by HPLC using a terguride-based… Expand
1999
1999
Metabolic transformations of flobufen, [4-(2',4'-difluoro-biphenyl-4-y1)-4-oxo-2-methylbutanoic acid], a non-steroid… Expand
1997
1997
The enantiomeric separation of an anti-inflammatory drug flobufen was performed on various chiral columns in liquid… Expand
1997
1997
Enantioseparation of 2-arylpropionic acids (Flobufen) and dansyl-derivatives of amino acids can be achieved in 10-15 min by… Expand
1990
1990
Pharmacokinetic study of the anti-inflammatory [3H] flobufen (I) and its active metabolite (II) has been carried out in rats… Expand